Hazard Hub

Product quality Recalls in Canada — Page 6

347 recalls involving product quality — most are health products recalls. Newest first, updated daily from government open data.

Showing 151–180 of 347

Health Products Type II
2024-11-29

Florabile: The total combined yeasts and molds count may be out of specification for the affected lots.

Product quality

View recall details →

Health Products Type II
2024-11-19

Pregabalin: Affected lot may contain partially full or empty capsules.

Product quality - Product safety

View recall details →

Health Products Type II
2024-11-14

JAMP-FeR: Yeasts and molds count is out of specification

Product quality

View recall details →

Health Products Type II
2024-11-14

PMS-PREGABALIN: Affected lot may contain empty capsules.

Product quality - Product safety

View recall details →

Health Products Type III
2024-11-13

Actifungi Cream: Affected batches do not comply with the conditions of the product marketing authorization.

Product quality

View recall details →

Health Products Type I
2024-11-08

Titanium 4000, Titanium 4000+: undeclared ingredient sildenafil.

Product quality - Unauthorized product

View recall details →

Health Products Type II
2024-11-05

COMPLETE 6000 WIPES: Out-of-specification (Sodium Hypochlorite content)

Product quality

View recall details →

Health Products Type II
2024-11-04

Florabile: Out of Specification

Product quality

View recall details →

Health Products Type II
2024-10-15

Jamp-Finasteride tablet; Out-of-specification (Finasteride content)

Product quality

View recall details →

Health Products Type II
2024-10-11

Stress-B-Plus Tablet: Contains Niacin instead of Niacinamide

Product quality

View recall details →

Health Products Type II
2024-09-27

Mint-Risperidon tablet: Out of specification (Impurity)

Product quality

View recall details →

Health Products Type II
2024-09-25

Cromolyn eye drops: Out of specification (Antimicrobial efficacy)

Product quality

View recall details →

Health Products Type II
2024-09-16

Refresh Lacri-Lube Ophthalmic ointment: Sterility concerns

Product quality

View recall details →

Health Products Type I
2024-09-13

Panhematin powder for solution: Sterility concern

Product quality

View recall details →

Health Products Type II
2024-09-11

Jamp Telmisartan-HCT tablet; Out-of-Specification (Assay)

Product quality

View recall details →

Health Products Type II
2024-09-11

AG Telmisartan-HCT Tablet: Out of specification (Assay)

Product quality

View recall details →

Health Products Type II
2024-09-09

Vitamin D3: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-09

Jamp-Acetaminophen tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-09

Jamp-Telmisartan tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-09

AG-Telmisartan tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type I
2024-09-06

JAMP-Clopidogrel : may contain overweight or underweight tablets

Product quality

View recall details →

Health Products Type I
2024-09-06

AG-Clopidogrel : may contain overweight or underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-06

JAMP-Pyridostigmine Bromide; Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-06

MJ Tonic Nigelle nasal; Out of specification (Peroxide and Acid value)

Product quality

View recall details →

Health Products Type II
2024-09-06

Immunig Nasal drops; Out of specification (Peroxide value)

Product quality

View recall details →

Health Products Type II
2024-08-09

Recall: Teva- Bupropion 300mg - lower strength tablet

Product quality

View recall details →

Health Products Type II
2024-08-07

Recall: JAMP Rabeprazole 10mg Over-sized delayed release tablets

Product quality

View recall details →

Health Products Type I
2024-08-05

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality - Labelling

View recall details →

Other
2024-08-03

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality

View recall details →

Health Products Type II
2024-06-27

Teva-Topilene 0.05% Ointment: Out of Specification

Product quality

View recall details →

Other Health Products Hazards

COVID (276)Labelling (71)Contamination (64)Packaging (46)

Browse all recalls by hazard, allergen & year →